Acumen Pharmaceuticals, Inc.(ABOS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABOS Acumen Pharmaceuticals, Inc.

交易中 08-27 13:17:21 EDT

3.13

+0.14

+4.52%

最高3.17	最低2.98	成交量17.57万
今开2.99	昨收2.99	日振幅6.35%
总市值2.26亿	流通市值1.16亿	总股本7,221万
成交额54.33万	换手率0.47%	流通股本3,705万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABOS","market":"US","secType":"STK","nameCN":"Acumen Pharmaceuticals, Inc.","latestPrice":3.125,"timestamp":1787850919683,"preClose":2.99,"halted":0,"volume":175729,"delay":0,"changeRate":0.04515050167224073,"floatShares":37045900,"shares":72212758,"eps":-1.637041,"marketStatus":"交易中","change":0.135,"latestTime":"08-27 13:17:21 EDT","open":2.99,"high":3.17,"low":2.98,"amount":543335.264997,"amplitude":0.063545,"askPrice":3.13,"askSize":1340,"bidPrice":3.12,"bidSize":554,"shortable":3,"etf":0,"ttmEps":-1.637041,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787860800000},"marketStatusCode":2,"adr":0,"listingDate":1625112000000,"exchange":"NASDAQ","adjPreClose":2.99,"preHourTrading":{"tag":"盘前","latestPrice":2.99,"preClose":2.99,"latestTime":"09:28 EDT","volume":106,"amount":323.8099872,"timestamp":1787837302069,"change":0,"changeRate":0,"amplitude":0.036789},"postHourTrading":{"tag":"盘后","latestPrice":2.99,"preClose":2.99,"latestTime":"19:30 EDT","volume":429,"amount":1280.424,"timestamp":1787787003537,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.706411,"impliedVol":0.865,"impliedVolPercentile":0.4821},"requestUrl":"/m/hq/s/ABOS","defaultTab":"news","newsList":[{"id":"1126004188","title":"Acumen Pharmaceuticals 双特异性抗体展现优于原生抗AβO抗体的脑渗透性","url":"https://stock-news.laohu8.com/highlight/detail?id=1126004188","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126004188?lang=zh_cn&edition=full","pubTime":"2026-07-15 19:35","pubTimestamp":1784115310,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals公司研发的Ebd双特异性抗体，在脑部渗透能力上展现出显著提升，其表现超越了传统的原生抗AβO抗体。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","ABOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130256716","title":"Acumen Pharmaceuticals宣布提名两款增强型脑部递送™ (EbD™) 开发候选药物用于治疗阿尔茨海默病","url":"https://stock-news.laohu8.com/highlight/detail?id=1130256716","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130256716?lang=zh_cn&edition=full","pubTime":"2026-06-16 19:31","pubTimestamp":1781609510,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals, Inc. 宣布，已提名两款基于其增强型脑部递送™ (EbD™) 技术平台的开发候选药物，用于治疗阿尔茨海默病。此举标志着该公司在攻克这一神经退行性疾病领域的研发管线取得了重要进展。\n这两款候选药物的提名，旨在利用其专有的EbD™技术，更有效地将治疗性分子递送至大脑靶点，以期改善阿尔茨海默病患者的治疗效果。公司计划推进相关临床前及后续的临床开发工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABOS","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103661010","title":"Acumen Pharmaceuticals公布2025财年业绩及业务亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=1103661010","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103661010?lang=zh_cn&edition=full","pubTime":"2026-03-26 19:02","pubTimestamp":1774522970,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals, Inc.（简称：Acumen Pharmaceuticals）近日正式披露了截至2025年12月31日的年度财务报告，并同步回顾了公司在过去一年中的关键业务进展。\n财务数据显示，公司在报告期内实现了稳健的运营表现。具体业绩指标及详细数据已在完整财报中列明，投资者可通过官方渠道获取进一步信息。\n业务层面，Acumen Pharmaceuticals在过去一年中取得了多项重要突破。其中包括核心研发管线的持续推进、关键临床研究项目的积极成果，以及战略合作方面的拓展。这些进展为公司的长期发展奠定了坚实基础，并展现出其在专业领域的创新实力与成长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617522045","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.59%报3.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617522045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2617522045?lang=zh_cn&edition=full","pubTime":"2026-03-05 22:35","pubTimestamp":1772721307,"startTime":"0","endTime":"0","summary":"北京时间2026年03月05日22时35分，Acumen Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.59%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一种新型疾病缓解方法，以针对其认为是阿尔茨海默病的关键潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305223507a6a72261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305223507a6a72261&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ABOS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165109744","title":"Acumen Pharmaceuticals将在2026年阿尔茨海默病与帕金森病国际会议上展示阿尔茨海默病治疗新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1165109744","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165109744?lang=zh_cn&edition=full","pubTime":"2026-03-03 21:03","pubTimestamp":1772543027,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals, Inc. (ABOS) 宣布，其将在2026年举行的阿尔茨海默病与帕金森病国际会议（International Conference on Alzheimer’s and Parkinson’s Diseases）上，公布公司在阿尔茨海默病治疗领域取得的最新研究进展。\n此次展示将重点聚焦于该公司在研疗法的最新数据，标志着其在攻克这一神经退行性疾病道路上迈出的关键一步。业界期待这些数据能为阿尔茨海默病的治疗带来新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516654373","title":"Acumen Pharmaceuticals, Inc.盘中异动 大幅下挫5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516654373?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:05","pubTimestamp":1741025113,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时05分，Acumen Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.47%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040205139637dded&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040205139637dded&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ABOS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514862334","title":"Acumen Pharmaceuticals, Inc.盘中异动 股价大跌5.22%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514862334?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:07","pubTimestamp":1740600466,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时07分，Acumen Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.22%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227040746a2554143&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227040746a2554143&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ABOS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514011121","title":"Acumen Pharmaceuticals, Inc.盘中异动 大幅下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514011121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514011121?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:34","pubTimestamp":1740501272,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时34分，Acumen Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.04%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003432abdc9b22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003432abdc9b22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511579498","title":"Acumen Pharmaceuticals, Inc.盘中异动 快速拉升5.11%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511579498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511579498?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:04","pubTimestamp":1739473464,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时04分，Acumen Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.11%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140304249621f034&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140304249621f034&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ABOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510387221","title":"Acumen Pharmaceuticals, Inc.盘中异动 股价大跌5.04%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510387221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510387221?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:36","pubTimestamp":1739284571,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时36分，Acumen Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.04%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223612abcb073b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223612abcb073b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ABOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505773298","title":"Acumen Pharmaceuticals, Inc.盘中异动 快速上涨5.52%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505773298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505773298?lang=zh_cn&edition=full","pubTime":"2025-01-23 01:01","pubTimestamp":1737565281,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日01时01分，Acumen Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.52%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123010121a22bd190&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123010121a22bd190&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ABOS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504914040","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.26%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504914040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504914040?lang=zh_cn&edition=full","pubTime":"2025-01-17 00:15","pubTimestamp":1737044139,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日00时15分，Acumen Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.26%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117001540a224780a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117001540a224780a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ABOS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503647436","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.45%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503647436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503647436?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:38","pubTimestamp":1736951935,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时38分，Acumen Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.45%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522385598673d5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522385598673d5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ABOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501775811","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘大幅跳水5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501775811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501775811?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:50","pubTimestamp":1736347818,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时50分，Acumen Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.34%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225018985f7c2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225018985f7c2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500692736","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500692736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500692736?lang=zh_cn&edition=full","pubTime":"2025-01-02 22:44","pubTimestamp":1735829077,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日22时44分，Acumen Pharmaceuticals, Inc.股票出现异动，股价急速拉升6.10%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501022244389858feb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501022244389858feb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ABOS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494733585","title":"Acumen Pharmaceuticals, Inc.盘中异动 快速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494733585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494733585?lang=zh_cn&edition=full","pubTime":"2024-12-28 01:47","pubTimestamp":1735321643,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日01时47分，Acumen Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.03%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412280147239851fb3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412280147239851fb3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ABOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494611578","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘急速下挫5.03%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494611578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494611578?lang=zh_cn&edition=full","pubTime":"2024-12-26 23:28","pubTimestamp":1735226883,"startTime":"0","endTime":"0","summary":"北京时间2024年12月26日23时28分，Acumen Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.03%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226232803a20aa11b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226232803a20aa11b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491869213","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491869213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491869213?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:38","pubTimestamp":1734359910,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时38分，Acumen Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.27%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223831a1f34638&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223831a1f34638&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ABOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491339846","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491339846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491339846?lang=zh_cn&edition=full","pubTime":"2024-12-13 00:28","pubTimestamp":1734020889,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日00时28分，Acumen Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.05%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213002809984b9b5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213002809984b9b5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABOS","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490664768","title":"Acumen Pharmaceuticals, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490664768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490664768?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:20","pubTimestamp":1733930436,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日23时20分，Acumen Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.02%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211232036984b5845&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211232036984b5845&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acumenpharm.com","stockEarnings":[{"period":"1week","weight":-0.0508},{"period":"1month","weight":0.3591},{"period":"3month","weight":0.1772},{"period":"6month","weight":-0.0478},{"period":"1year","weight":1.0479},{"period":"ytd","weight":0.4171}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.0365},{"period":"3month","weight":0.0152},{"period":"6month","weight":0.1168},{"period":"1year","weight":0.1874},{"period":"ytd","weight":0.1234}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acumen Pharmaceuticals, Inc.于1996年在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，正在开发一种新的疾病改善方法，以针对该公司认为是阿尔茨海默病或AD的关键根本原因。阿尔茨海默病是一种大脑进行性神经退行性疾病，会导致记忆和认知功能丧失，最终导致死亡。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.018698},{"month":2,"riseRate":0.6,"avgChangeRate":0.072607},{"month":3,"riseRate":0,"avgChangeRate":-0.202345},{"month":4,"riseRate":0.4,"avgChangeRate":-0.0454},{"month":5,"riseRate":0.4,"avgChangeRate":0.019573},{"month":6,"riseRate":0.6,"avgChangeRate":0.05813},{"month":7,"riseRate":0.8,"avgChangeRate":0.214337},{"month":8,"riseRate":0.5,"avgChangeRate":0.034921},{"month":9,"riseRate":0.4,"avgChangeRate":0.088763},{"month":10,"riseRate":0.4,"avgChangeRate":-0.092058},{"month":11,"riseRate":0.2,"avgChangeRate":-0.138923},{"month":12,"riseRate":0.4,"avgChangeRate":0.05729}],"exchange":"NASDAQ","name":"Acumen Pharmaceuticals, Inc.","nameEN":"Acumen Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acumen Pharmaceuticals, Inc.(ABOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acumen Pharmaceuticals, Inc.(ABOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acumen Pharmaceuticals, Inc.,ABOS,Acumen Pharmaceuticals, Inc.股票,Acumen Pharmaceuticals, Inc.股票老虎,Acumen Pharmaceuticals, Inc.股票老虎国际,Acumen Pharmaceuticals, Inc.行情,Acumen Pharmaceuticals, Inc.股票行情,Acumen Pharmaceuticals, Inc.股价,Acumen Pharmaceuticals, Inc.股市,Acumen Pharmaceuticals, Inc.股票价格,Acumen Pharmaceuticals, Inc.股票交易,Acumen Pharmaceuticals, Inc.股票购买,Acumen Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acumen Pharmaceuticals, Inc.(ABOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acumen Pharmaceuticals, Inc.(ABOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}